Published in J Sex Med on February 05, 2010
Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med (2010) 1.87
Stem cell therapy for erectile dysfunction: a critical review. Stem Cells Dev (2011) 1.44
Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury. Eur Urol (2011) 1.17
Adipose tissue-derived stem cells secrete CXCL5 cytokine with neurotrophic effects on cavernous nerve regeneration. J Sex Med (2010) 1.16
Adipose tissue stem cells: the great WAT hope. Trends Endocrinol Metab (2012) 1.05
Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic properties. Biochem Biophys Res Commun (2010) 1.00
Tracking intracavernously injected adipose-derived stem cells to bone marrow. Int J Impot Res (2011) 0.99
Both immediate and delayed intracavernous injection of autologous adipose-derived stromal vascular fraction enhances recovery of erectile function in a rat model of cavernous nerve injury. Eur Urol (2012) 0.99
Stem cell therapy in bladder dysfunction: where are we? And where do we have to go? Biomed Res Int (2013) 0.96
Advances in stem cell therapy for the lower urinary tract. World J Stem Cells (2010) 0.95
Regenerative repair of damaged meniscus with autologous adipose tissue-derived stem cells. Biomed Res Int (2014) 0.95
Adipose tissue-derived stem cells ameliorate diabetic bladder dysfunction in a type II diabetic rat model. Stem Cells Dev (2011) 0.94
Treatment of bladder dysfunction using stem cell or tissue engineering technique. Korean J Urol (2014) 0.92
Cavernous smooth muscle hyperplasia in a rat model of hyperlipidaemia-associated erectile dysfunction. BJU Int (2011) 0.92
Effects of EdU labeling on mesenchymal stem cells. Cytotherapy (2013) 0.92
Separate or combined treatments with daily sildenafil, molsidomine, or muscle-derived stem cells prevent erectile dysfunction in a rat model of cavernosal nerve damage. J Sex Med (2012) 0.88
Stem cells: novel players in the treatment of erectile dysfunction. Asian J Androl (2011) 0.86
Prospects of stem cell treatment in benign urological diseases. Korean J Urol (2015) 0.85
Erectile dysfunction precedes coronary artery endothelial dysfunction in rats fed a high-fat, high-sucrose, Western pattern diet. J Sex Med (2012) 0.85
Chronic Cigarette Smoking Impairs Erectile Function through Increased Oxidative Stress and Apoptosis, Decreased nNOS, Endothelial and Smooth Muscle Contents in a Rat Model. PLoS One (2015) 0.84
Emerging tools for erectile dysfunction: a role for regenerative medicine. Nat Rev Urol (2012) 0.82
Stem cell therapy for voiding and erectile dysfunction. Nat Rev Urol (2012) 0.81
Urine-derived stem cells: A novel and versatile progenitor source for cell-based therapy and regenerative medicine. Genes Dis (2014) 0.81
Adrenomedullin as a growth and cell fate regulatory factor for adult neural stem cells. Stem Cells Int (2012) 0.79
Isolation and passage of muscle-derived stem cells from the rat penile corpora cavernosa and induction of differentiation into smooth muscle cells. Cytotechnology (2013) 0.78
Senescent Cells Impair Erectile Function through Induction of Endothelial Dysfunction and Nerve Injury in Mice. PLoS One (2015) 0.78
A novel method to establish a rat ED model using internal iliac artery ligation combined with hyperlipidemia. PLoS One (2014) 0.77
Therapeutic angiogenesis as a potential future treatment strategy for erectile dysfunction. World J Mens Health (2012) 0.77
Combined effects of brain-derived neurotrophic factor immobilized poly-lactic-co-glycolic acid membrane with human adipose-derived stem cells and basic fibroblast growth factor hydrogel on recovery of erectile dysfunction. Tissue Eng Part A (2014) 0.76
Sexual dysfunction: The potential of stem cell therapy for Peyronie disease. Nat Rev Urol (2012) 0.76
Stem-cell therapy for erectile dysfunction. Arab J Urol (2013) 0.76
Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction? J Transl Med (2013) 0.75
The Current Status of Stem-Cell Therapy in Erectile Dysfunction: A Review. World J Mens Health (2016) 0.75
The Effects of Adipose-Derived Stem Cells in a Rat Model of Tobacco-Associated Erectile Dysfunction. PLoS One (2016) 0.75
A comparative assessment of adipose-derived stem cells from subcutaneous and visceral fat as a potential cell source for knee osteoarthritis treatment. J Cell Mol Med (2017) 0.75
Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation (2004) 6.90
Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol (2004) 3.12
Defining stem and progenitor cells within adipose tissue. Stem Cells Dev (2008) 2.63
Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen (2009) 2.33
Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med (2008) 2.23
Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol (1994) 1.75
Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation (2006) 1.73
Chapter 1: The management of erectile dysfunction: an AUA update. J Urol (2005) 1.55
Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet (1985) 1.45
Overview of phosphodiesterase 5 inhibition in erectile dysfunction. Am J Cardiol (2003) 1.39
Fibroblast growth factor 2 promotes endothelial differentiation of adipose tissue-derived stem cells. J Sex Med (2008) 1.35
Nitric oxide and the endothelium: history and impact on cardiovascular disease. Vascul Pharmacol (2006) 1.35
Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res (2007) 1.30
Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage. J Urol (2004) 1.29
First-dose success with vardenafil in men with erectile dysfunction and associated comorbidities: RELY-I. Int J Clin Pract (2006) 1.22
Erectile dysfunction and dyslipidemia: relevance and role of phosphodiesterase type-5 inhibitors and statins. J Sex Med (2008) 1.09
Intracavernous growth differentiation factor-5 therapy enhances the recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med (2008) 1.05
Intracavernosal injection of vascular endothelial growth factor induces nitric oxide synthase isoforms. BJU Int (2002) 1.03
Downregulation of angiogenic factors and their downstream target molecules affects the deterioration of erectile function in a rat model of hypercholesterolemia. Urology (2006) 1.02
The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment. Diabet Med (2006) 0.95
Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells? FASEB J (2002) 0.89
Intracavernosal basic fibroblast growth factor improves vasoreactivity in the hypercholesterolemic rabbit. J Sex Med (2006) 0.85
American Urological Association guideline on the management of priapism. J Urol (2003) 3.77
Clinically insignificant residual fragments: an acceptable term in the computed tomography era? Urology (2013) 3.45
Defining stem and progenitor cells within adipose tissue. Stem Cells Dev (2008) 2.63
Molecular mechanisms related to parturition-induced stress urinary incontinence. Eur Urol (2008) 2.17
Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J Sex Med (2010) 1.99
Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol (2002) 1.96
Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol (2010) 1.95
Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn (2011) 1.93
An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE). J Sex Med (2014) 1.91
Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med (2010) 1.87
Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am (2005) 1.81
RNAa is conserved in mammalian cells. PLoS One (2010) 1.81
Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation (2006) 1.73
Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy (2010) 1.71
T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism. J Urol (2009) 1.69
Upregulation of penile brain-derived neurotrophic factor (BDNF) and activation of the JAK/STAT signalling pathway in the major pelvic ganglion of the rat after cavernous nerve transection. Eur Urol (2006) 1.67
Brain activation and sexual arousal in healthy, heterosexual males. Brain (2002) 1.62
Complications of porcine small intestine submucosa graft for Peyronie's disease. J Urol (2007) 1.57
Chapter 1: The management of erectile dysfunction: an AUA update. J Urol (2005) 1.55
Penile sonographic and clinical characteristics in men with Peyronie's disease. J Sex Med (2009) 1.55
Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction. J Urol (2002) 1.54
Socioeconomic, anthropomorphic, and demographic predictors of adult sexual activity in the United States: data from the national survey of family growth. J Sex Med (2009) 1.54
Erection of the human penis and its morphological and vascular basis by Guiseppe Conti. J Sex Med (2008) 1.45
Labeling and tracking of mesenchymal stromal cells with EdU. Cytotherapy (2009) 1.45
Prevalence and predictors of sexual problems, relationship stress, and depression in female partners of infertile couples. J Sex Med (2008) 1.45
Effects of high glucose on human cavernous endothelial cells. Urology (2012) 1.44
Stem cell therapy for erectile dysfunction: a critical review. Stem Cells Dev (2011) 1.44
Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev (2012) 1.44
Improving erectile function by silencing phosphodiesterase-5. J Urol (2005) 1.43
Cavernous nerve repair with allogenic adipose matrix and autologous adipose-derived stem cells. Urology (2011) 1.43
Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2010) 1.42
Critical analysis of outcome after open dismembered pyeloplasty in ectopic pelvic kidneys in a pediatric cohort. Urology (2012) 1.42
Phimosis with Preputial Fissures as a Predictor of Undiagnosed Type 2 Diabetes in Adults. Acta Derm Venereol (2016) 1.39
The use of complementary and alternative fertility treatment in couples seeking fertility care: data from a prospective cohort in the United States. Fertil Steril (2010) 1.39
The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int (2004) 1.37
Fibroblast growth factor 2 promotes endothelial differentiation of adipose tissue-derived stem cells. J Sex Med (2008) 1.35
A pathophysiology-based approach to the management of early priapism. Asian J Androl (2012) 1.35
Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med (2010) 1.35
T-shunt with or without tunnelling for prolonged ischaemic priapism. BJU Int (2008) 1.33
Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model. J Sex Med (2012) 1.30
Multiple conformations of phosphodiesterase-5: implications for enzyme function and drug development. J Biol Chem (2006) 1.29
AUA guideline on the pharmacologic management of premature ejaculation. J Urol (2004) 1.28
An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat. BJU Int (2007) 1.27
Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int (2005) 1.24
Peyronie's disease (CME). J Sex Med (2007) 1.24
Up-regulation of estrogen responsive genes in hypospadias: microarray analysis. J Urol (2007) 1.23
CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation. J Biol Chem (2005) 1.21
Expression, distribution and regulation of phosphodiesterase 5. Curr Pharm Des (2006) 1.20
Label retaining and stem cell marker expression in the developing rat urinary bladder. Urology (2011) 1.19
Stem cell therapy for stress urinary incontinence: a critical review. Stem Cells Dev (2012) 1.18
Adipose derived stem cells ameliorate hyperlipidemia associated detrusor overactivity in a rat model. J Urol (2010) 1.17
Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury. Eur Urol (2011) 1.17